DeepMind plans to unleash an artificial intelligence product capable of diagnosing 50 ophthalmic conditions from a simple OCT scan, the company reports. Source: AAO
This cluster-randomized, intervention-controlled study examined the effect of a school-based program encouraging outdoor activities on myopia. Source: AAO
Sun Pharmaceuticals announced the approval of their preservative-free nanomicellar formulation of cyclosporine A for increasing tear production in patients with dry eye disease. Source: AAO
This week, retinal thinning heralds the onset of Parkinson’s disease, a piezo-print technology dots the cornea with a miniscule amount of latanoprost and sheep with achromatopsia wake up to good news about the benefits of CNGA3 gene therapy. Source: AAO
This study compares the efficacy and safety of intravitreous ranibizumab versus panretinal photocoagulation over 5 years of treatment in patients with proliferative diabetic retinopathy. Source: AAO
The FDA has approved the use of the Hydrus microstent in conjunction with cataract surgery to reduce IOP in patients with mild to moderate primary open-angle glaucoma. Source: AAO
Researchers assessed the efficacy of oral voriconazole for treating filamentous fungal keratitis. Source: AAO
The body’s own immune system destroys retinal cells and drives glaucomatous neurodegeneration, researchers reported August 10 in the journal Nature Communications. Source: AAO
In this case series, researchers describe 3 cancer patients who developed uveal effusion while taking immune checkpoint inhibitors. Source: AAO
This retrospective cohort study analyzed whether differences in ocular biometry measurements between eyes could predict refractive outcomes after cataract surgery. Source: AAO